ロード中...
Influence of Competing Risks on Estimating the Expected Benefit of Warfarin Among Atrial Fibrillation Patients not Currently Taking Anticoagulants: the ATRIA Study
BACKGROUND/OBJECTIVES: To date, studies examining the association between warfarin therapy and incidence of ischemic stroke among patients with atrial fibrillation (AF) have not accounted for the competing risk of death. Competing risk analysis may provide greater understanding of the “real world” i...
保存先:
| 出版年: | J Am Geriatr Soc |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5258686/ https://ncbi.nlm.nih.gov/pubmed/27861698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.14516 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|